Tiziana Fierro

Strada Vicinale Via Delle Corse, S. Andrea Delle Fratte
Perugia, 06132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes.

High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes.

Journal: Coronary artery disease

Published: August 01, 2024

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

Journal: Scientific reports

Published: December 22, 2023

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 26, 2020

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.

Journal: International journal of cardiology

Published: April 30, 2020

Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia.

Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia.

Journal: Platelets

Published: March 24, 2020

Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry).

Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry).

Journal: The American journal of cardiology

Published: June 10, 2019

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial.

Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial.

Journal: Haematologica

Published: April 08, 2019

Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs.

Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs.

Journal: Thrombosis research

Published: October 16, 2018

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

Journal: Blood

Published: April 30, 2018

First Diagnosis of Hemophilia B in a Nonagenarian.

First Diagnosis of Hemophilia B in a Nonagenarian.

Journal: Journal of the American Geriatrics Society

Published: January 20, 2016

Reasons for visits to an emergency center and hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage.

Reasons for visits to an emergency center and hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage.

Journal: European journal of ophthalmology

Published: September 23, 2015

Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.

Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.

Journal: Ear and hearing

Published: July 31, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026